524940-50-9Relevant articles and documents
Highly potent non-peptidic inhibitors of the HCV NS3/NS4A serine protease
Sperandio, David,Gangloff, Anthony R.,Litvak, Joane,Goldsmith, Richard,Hataye, Jason M.,Wang, Vivian R.,Shelton, Emma J.,Elrod, Kyle,Janc, James W.,Clark, James M.,Rice, Ken,Weinheimer, Steve,Yeung, Kap-Sun,Meanwell, Nicholas A.,Hernandez, Dennis,Staab, Andrew J.,Venables, Brian L.,Spencer, Jeffrey R.
, p. 3129 - 3133 (2007/10/03)
Screening of a diverse set of bisbenzimidazoles for inhibition of the hepatitis C virus (HCV) serine protease NS3/NS4A led to the identification of a potent Zn2+-dependent inhibitor (1). Optimization of this screening hit afforded a 10-fold more potent inhibitor (46) under Zn2+ conditions (Ki=27 nM). This compound (46) binds also to NS3/NS4A in a Zn2+ independent fashion (Ki=1 μM). The SAR of this class of compounds under Zn2+ conditions is highly divergent compared to the SAR in the absence of Zn2+, suggesting two distinct binding modes.